Idorsia Ltd (IDRSF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.2 Billion CHF | -1.93% |
| 2022 | 1.22 Billion CHF | 5.49% |
| 2021 | 1.16 Billion CHF | 82.37% |
| 2020 | 637.98 Million CHF | 1.06% |
| 2019 | 631.32 Million CHF | 10.6% |
| 2018 | 570.84 Million CHF | 56.53% |
| 2017 | 364.68 Million CHF | 24.29% |
| 2016 | 293.42 Million CHF | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.26 Billion CHF | 0.32% |
| 2024 Q1 | 1.26 Billion CHF | 4.79% |
| 2023 Q4 | 1.2 Billion CHF | -0.14% |
| 2023 Q2 | 1.23 Billion CHF | 0.99% |
| 2023 FY | 1.2 Billion CHF | -1.93% |
| 2023 Q1 | 1.22 Billion CHF | -0.19% |
| 2023 Q3 | 1.2 Billion CHF | -2.58% |
| 2022 Q2 | 1.2 Billion CHF | 0.36% |
| 2022 Q4 | 1.22 Billion CHF | 2.24% |
| 2022 FY | 1.22 Billion CHF | 5.49% |
| 2022 Q1 | 1.19 Billion CHF | 2.96% |
| 2022 Q3 | 1.2 Billion CHF | -0.15% |
| 2021 Q1 | 637.83 Million CHF | -0.02% |
| 2021 FY | 1.16 Billion CHF | 82.37% |
| 2021 Q4 | 1.16 Billion CHF | -7.34% |
| 2021 Q3 | 1.25 Billion CHF | 96.66% |
| 2021 Q2 | 638.49 Million CHF | 0.1% |
| 2020 Q4 | 637.98 Million CHF | 0.62% |
| 2020 FY | 637.98 Million CHF | 1.06% |
| 2020 Q1 | 631.79 Million CHF | 0.07% |
| 2020 Q3 | 634.03 Million CHF | 0.19% |
| 2020 Q2 | 632.81 Million CHF | 0.16% |
| 2019 Q2 | 630.37 Million CHF | 1.03% |
| 2019 Q4 | 631.32 Million CHF | -0.03% |
| 2019 FY | 631.32 Million CHF | 10.6% |
| 2019 Q3 | 631.53 Million CHF | 0.18% |
| 2019 Q1 | 623.92 Million CHF | 9.3% |
| 2018 Q3 | 568.81 Million CHF | 54.36% |
| 2018 FY | 570.84 Million CHF | 56.53% |
| 2018 Q2 | 368.48 Million CHF | 0.52% |
| 2018 Q1 | 366.57 Million CHF | 0.52% |
| 2018 Q4 | 570.84 Million CHF | 0.36% |
| 2017 Q1 | 296.88 Million CHF | 0.0% |
| 2017 FY | 364.68 Million CHF | 24.29% |
| 2017 Q4 | 364.68 Million CHF | 0.53% |
| 2017 Q3 | 362.76 Million CHF | 0.5% |
| 2017 Q2 | 360.95 Million CHF | 21.58% |
| 2016 FY | 293.42 Million CHF | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bioxytran, Inc. | 1.92 Million USD | -62426.026% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -2821.21% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -299421.96% |
| SQZ Biotechnologies Company | 27.47 Million USD | -4281.442% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -51647.605% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -2675.058% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -3943.472% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -126828.484% |
| Marizyme, Inc. | 18.71 Million USD | -6330.487% |
| Genus plc | 233.1 Million USD | -416.356% |
| Pharming Group N.V. | 171.54 Million USD | -601.639% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -135433.7% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -89483.234% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -160383.467% |
| ContraFect Corporation | 2.88 Million USD | -41678.063% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -83119.954% |
| IMV Inc. | 28.88 Million USD | -4067.118% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -21171.667% |
| ONE Bio Corp. | 19.71 Million USD | -6005.122% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -1993.663% |
| Mesoblast Limited | 118.7 Million USD | -914.003% |
| MultiCell Technologies, Inc. | 202.58 USD | -594148384.549% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -3536.222% |
| Genscript Biotech Corporation | 417.73 Million USD | -188.129% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -190928.398% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -97886.341% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -29100.353% |
| Biomind Labs Inc. | 735.54 Thousand USD | -163537.97% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -39673.63% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -9160.802% |
| Skye Bioscience, Inc. | 4.61 Million USD | -25979.234% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -334510.103% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -40973.947% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -850410.889% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -888270.102% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -20400.895% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -4679809.794% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -80423.512% |
| Q BioMed Inc. | 4.1 Million USD | -29185.44% |
| GB Sciences, Inc. | 1.75 Million USD | -68314.779% |
| Alpha Cognition Inc. | 1.22 Million USD | -98527.795% |
| CSL Limited | 12.18 Billion USD | 90.12% |
| Agentix Corp. | 50 Thousand USD | -2407152.0% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -1679.384% |
| Enzolytics Inc. | 996.33 Thousand USD | -120704.988% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 6.49 Million USD | -18442.998% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -470816.93% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -53195.967% |
| argenx SE | 20 Million USD | -5918.13% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -2541.848% |
| HST Global, Inc. | 98.31 Thousand USD | -1224104.884% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -483828.112% |
| Halberd Corporation | 150 Thousand USD | -802317.333% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -16917.649% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -11771303.423% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -44335.51% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -50098.688% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -524833.818% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -809582.888% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -599865.107% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.19 Million USD | -54613.257% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -5821.025% |
| Kadimastem Ltd | 891.22 Thousand USD | -134952.837% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | -25447.006% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -481000.159% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | 33.6 Thousand USD | -3581480.67% |
| Cell Source, Inc. | 9.25 Million USD | -12906.304% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -159066.839% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -159066.839% |
| Affymax, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -248437.222% |
| Itoco Inc. | 228.37 Thousand USD | -526934.684% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -570406.458% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -24054.646% |
| International Stem Cell Corporation | 4.17 Million USD | -28708.664% |
| CytoDyn Inc. | 30.07 Million USD | -3901.948% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -341987.896% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -15291.716% |
| SYBLEU INC | 477.5 Thousand USD | -251968.272% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -982451.837% |
| Rebus Holdings, Inc. | 310 Thousand USD | -388166.452% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -25318.254% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -1928386.053% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -55089.417% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -14373.617% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -13920.105% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -77279.765% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -449014.179% |
| Neutra Corp. | 54.15 Thousand USD | -2222416.434% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -65671.913% |
| PureTech Health plc | 25.51 Million USD | -4617.882% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -98217.304% |
| IXICO plc | 472.02 Thousand USD | -254893.083% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -7664.828% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -1833.132% |
| CSL Limited | 12.18 Billion USD | 90.12% |
| Cellectis S.A. | 92.77 Million USD | -1197.339% |